HODGKIN'S LYMPHOMA
Clinical trials for HODGKIN'S LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new HODGKIN'S LYMPHOMA trials appear
Sign up with your email to follow new studies for HODGKIN'S LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Engineered t cells take on lymphoma in early trial
Disease control Recruiting nowThis early-phase study tests a new treatment for people with Hodgkin or non-Hodgkin lymphoma that has returned or not responded to standard therapy. The treatment uses the patient's own T cells, which are genetically modified to recognize and attack cancer cells carrying the CD30…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New drug combo aims to tackle resistant Hodgkin's lymphoma
Disease control Recruiting nowThis phase II trial tests whether combining two drugs—azacitidine and pembrolizumab—can help people with Hodgkin's lymphoma that has come back or stopped responding to treatment. About 24 participants will receive both drugs by IV. The main goal is to see how many patients respon…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New inhaled drug aims to stop lung infections in vulnerable blood cancer patients
Disease control Recruiting nowThis study tests an experimental inhaled drug called PUL-042 in 100 people with blood cancers or who have had a stem cell transplant and have a viral lung infection. Participants receive either the drug or a placebo three times over six days. The goal is to see if PUL-042 can red…
Matched conditions: HODGKIN'S LYMPHOMA
Phase: PHASE2 • Sponsor: Pulmotect, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New study tracks Cancer's lasting impact on Women's sexual and fertility health
Knowledge-focused Recruiting nowThis study follows 475 women with breast cancer or lymphoma to understand how their treatments affect sexual function and fertility. Participants complete questionnaires and may optionally provide blood samples to measure ovarian health. The goal is to learn about these long-term…
Matched conditions: HODGKIN'S LYMPHOMA
Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC